For injection dosing, see our GHK-Cu injection dosage guide
While several compounds are promoted via social media claiming benefits of tissue repair, skin rejuvenation and anti-aging, we are particularly alarmed by the number of patients in our public multidisciplinary obesity clinic admitting to the use of unregulated products for weight loss, presumed to be pharmaceutical grade glucagon-like peptide-1 receptor agonists (GLP-1RA)
There was considerable variation in risk of suicidal thoughts and behaviors among drugs, but there was an increased risk identified in young patients for most drugs studied
Addressing obesity through weight management strategies, including pharmacologic ones like GLP-1 receptor agonists, is a key component of reducing all operative risks, improving surgical outcomes, and enhancing the long-term success of orthopedic interventions
Schwartzenberg-Bar-Yoseph, F., Armoni, M